To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Local Lidocaine Plus Ketorolac Superior to Lidocaine Alone for Pain Relief After Core Needle Biopsy

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
April 2021

Local Lidocaine Plus Ketorolac Superior to Lidocaine Alone for Pain Relief After Core Needle Biopsy

Vol: 17| Issue: 1| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Ketorolac plus Lidocaine vs Lidocaine for pain relief following core needle soft tissue biopsy: A CONSORT-compliant double-blind randomized controlled study

Medicine (Baltimore). 2021 Feb 19;100(7): e24721.

Contributing Authors:
T Chobpenthai T Ingviya P Thanindratarn R Jaiwithee K Sutthivaiyakit

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and twenty-eight patients with musculoskeletal tumours and scheduled for a core needle biopsy were randomized to receive a pre-biopsy injection of 10 mL 2% lidocaine plus adrenaline (n=64) or 10 mL 2% lidocaine plus adrenaline plus 30 mg of ketorolac (n=64) for the relief of post-procedural pain. The outcome of interest was pain severity after injection evaluated on a Visual Analogue S...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue